If a patient is on long term prednisone from PCP for refractory AD can that patient also start a JAK?
Featuring Brad Glick, DO, MPH | AAD Board of DirectorsProgram Director, Dermatology Residency, Larkin Health System, Palm Springs CampusAssistant Clinical Professor of Dermatology, Herbert Wertheim College of MedicineMiami, Florida | Published July 03, 2023
Related Media
Powered by Polaris TM